4th Quarter - Report

THE NICKLES GROUP, LLC for CSL BEHRING LLC

Period 4th Quarter 2019 Filed Jan 21, 2020 Signed by Mary Beth Savary Taylor

Official filing
Firm
THE NICKLES GROUP, LLC
Client
CSL BEHRING LLC
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

H.R. 1158, the Consolidated Appropriations Act of 2020; H.R. 1865, Further Consolidated Appropriations Act, 2020, as it relates to the self-administered drug list.

Foreign entity interest: CSL Limited, identified on Registration (LD-1), has an interest in activities of its U.S. subsidiary CSL Behring LLC on all issues.

LobbyistCovered position, as disclosed
STACEY HUGHES —
EMILY PORTER —
MARY BETH SAVARY TAYLOR —

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1158 (116th), H.R. 1865 (116th)

Health Issues HCR

Monitored issues related to prescription drug pricing. H.R. 2296, the METRIC Act. Monitored S. 1895, Lower Health Care Costs Act of 2019, as it relates to pricing transparency and drug pricing. H.R. 2113, Prescription Drug STAR Act.

Foreign entity interest: CSL Limited, identified on Registration (LD-1), has an interest in activities of its U.S. subsidiary CSL Behring LLC on all issues.

LobbyistCovered position, as disclosed
STACEY HUGHES —
EMILY PORTER —
MARY BETH SAVARY TAYLOR —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 1895 (116th), H.R. 2113 (116th), H.R. 2296 (116th)

Medicare/Medicaid MMM

Issues related to home infusion and DME self-administered therapies. Issues regarding coverage reimbursement of biologics and plasma therapies. Issues pertaining to drugs listed on the Self-Administered Drug list. H.R. 2296, the METRIC Act. Monitored issues related to H.R. 2905, Medicare IVIG Access Enhancement Act. H.R. 2113, Prescription Drug STAR Act. Monitored S. 2543, Prescription Drug Pricing Reduction Act of 2019. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.

Foreign entity interest: CSL Limited, identified on Registration (LD-1), has an interest in activities of its U.S. subsidiary CSL Behring LLC on all issues.

LobbyistCovered position, as disclosed
STACEY HUGHES —
EMILY PORTER —
MARY BETH SAVARY TAYLOR —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 2543 (116th), H.R. 2113 (116th), H.R. 2905 (116th), H.R. 3 (116th), H.R. 2296 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.